# Step 177 — PC07.10 encounter Medication Summary implementation

2026-10-24 (America/Toronto). **Medication Summary select/record/edit/discontinue implemented and verified in isolated tests; NOT DEPLOYED. No new migration or clinical table.** Reuses PatientMedication and existing stored procedures, adds an atomic encounter context/provenance transaction and inline SOAP/Progress panel. **29 new focused .NET cases and 27 affected regression cases have final PASS outcomes (56 distinct cases).** No Step 176 142-case rerun. No clinical authentication, deployed fixtures/writes or shared database access. **PC07.10 remains PARTIAL — IMPLEMENTED, deployment acceptance pending; PC07.01 PARTIAL; inventory 8 IDs / three packages.**

## 1. Authorization and Git baseline

The owner explicitly stated **“I authorize Step 177 implementation.”** Read AGENTS.md first and retained [Step 175 decisions](247-step175-pc07-10-encounter-cpp-design.md), [Step 176 foundation/evidence](248-step176-pc07-10-procedure-foundation-implementation.md), and existing medication contracts/tests. No prescribing change was authorized.

The actual workspace had changed since Step 176: **main was clean**, HEAD **68392e4 — pc07-10 ecnounter procedures**, with Step 176 incorporated and its former feature branch absent. Read-only branch/commit checks established this; no agent commit/merge/deletion was performed. Recreated the **same local branch name**, **feature/step-176-pc07-10-encounter-procedures**, at current main, avoiding an unnecessary second branch or a return to stale code. No pre-existing uncommitted file was overwritten. No commits, merges, pushes, resets, cleans, stashes or remote/GitHub operations.

## 2. Implemented medication actions and source separation

| Action from eligible Open SOAP/Progress context | Authoritative behavior |
|---|---|
| **Select existing** | Reads the patient's current PatientMedication entries and fills the inline editor. No Create, association-table insertion or clinical mutation |
| **Record medication** | Explicitly creates a new longitudinal Medication Summary entry through **PatientMedication_Create**, with current fields/validation and explicit Ongoing/Acute/unknown classification. Never infers ongoing treatment from blank input |
| **Edit existing** | Updates the selected **MedicationUid** through **PatientMedication_Update**, reviewed source/context versions and trusted actor. Existing unedited PlanFields/compliance groups remain preserved through their current omission contract |
| **Discontinue** | Explicit confirmed **PatientMedication_Discontinue**, current source version and optional reason; retains the record, audit/history and prior classification/clinical content. No physical deletion or reactivation shortcut |

The new surface edits Active records; existing Inactive/Discontinued records remain retrievable/read-only. It introduces no status value or changed global lifecycle meaning. Start/end-date and discontinuation rules are the existing medication rules. PrescriberName remains recorded medication information, not a trusted prescribing identity.

**PatientMedication, PatientPrescription and encounter narrative remain distinct.** The new service/repository never calls a prescription create, renewal, cancellation, transmission, finalization, correction or artifact operation. No automatic prescription-to-summary conversion, fuzzy reconciliation, silent duplicate merging or narrative inference. New medication recording is an explicit clinical action. Selecting an existing row never clones it.

Actual isolated tests perform the new record/edit/discontinue sequence alongside a **real finalized prescription and signed artifact**, then compare full prescription JSON and the original artifact unchanged. This is executed isolated SQL evidence, not a claim about a deployed clinical session.

## 3. Reused components and changed files

| Area | Actual additions/changes |
|---|---|
| Application | **PatientEncounters/EncounterMedications.cs**: typed action/save DTO, read state, service/repository contracts, validation, permissions, trusted actor and encounter scope. Reuses medication DTOs/classification/validation and the Step 176 service pattern |
| Infrastructure | **PatientEncounters/EncounterMedicationRepository.cs**: one selected-tenant connection/transaction, locking context/source reads, existing medication procedures and existing encounter-history provenance/replay receipt |
| Existing medication repository | **PatientMedications/PatientMedicationRepository.cs**: extracts the existing Create/Update/Discontinue command construction into internal reusable builders and exposes the existing response mapper internally. Ordinary APIs retain their own connection handling, parameter semantics and error/logging paths; no SQL definition changes |
| API | **Controllers/EncounterMedicationsController.cs**: thin authenticated GET/POST `/api/patients/{patientUid}/encounters/{encounterUid}/medications`, current permission/sensitive-capability conventions, NoStore and safe errors |
| Web transport | **Controllers/EncounterMedicationsController.cs**, **Services/PatientEncounters/EncounterMedicationApiClient.cs**, Program registration: GET/POST `/encounter-medications?patientUid=…&encounterUid=…`, normal token forwarding and Web antiforgery |
| Inline UI | **Views/Patients/_EncounterMedications.cshtml**, **ClientApp/patient-encounters/medications.ts**, Details composition/module reference: patient-medication selector, explicit Record, edit fields, confirmed Discontinue, status feedback and reload |
| CPP refresh | A narrow **cppMedicationItems** content wrapper in existing Details markup. New module refreshes actual current source rows after save, renders only Active Ongoing treatments, preserves the existing five-row/date ordering and preference field keys. Acute/unknown/stopped records remain in the full selector |
| Encounter coordination | Small **procedures.ts** busy guard so procedure and medication operations cannot overlap; new module consumes existing note/diagnosis/contribution context events and preserves dirty note text. Details resets cached encounter history after medication saves |
| History presentation | Application and Web **PatientEncounterHistoryResponse** plus Details: readable descriptions for new medication events; internal replay receipt data remains auditable without becoming displayed clinical prose. Other history descriptions retain their previous behavior |
| Registration/assets | Application/Infrastructure DI, Web HttpClient registration, new medication JS/map and affected procedure JS/map. No new dependencies |

New tests: **EncounterMedicationTests.cs**, **EncounterMedicationSqlTests.cs**, **EncounterMedicationPrescriptionTests.cs**, **tests/pc07-encounter-medications.test.cjs**. No existing test or SQL migration rewritten. Source and new-file whitespace/diff checks are recorded below.

## 4. Atomicity, scope, actor, concurrency and audit

**Read:** normal authentication, **Encounters.View + Patients.View**, owned patient/encounter, trusted active actor and existing fail-closed chart-read audit. The GET returns only selected-tenant patient medications and checks every returned patient's identity.

**Write:** additionally **Encounters.Edit + ClinicalData.Manage**. Web requires antiforgery; API/Application repeat authorization independent of hidden controls. The trusted actor comes from existing **IAuthenticatedClinicalUserAccessor**; actor/CreatedBy values added to a client JSON request cannot influence attribution. Neither tenant nor trusted prescriber identity is accepted from that payload.

Repository sequence, all in one outer **SqlTransaction**:

1. Open through **ITenantSqlConnectionFactory**. Lock the live patient and matching encounter in the established patient → encounter order with **UPDLOCK/HOLDLOCK**. Verify **Open** and the reviewed encounter RowVersion under those locks.
2. Verify active actor. Inspect a same-patient/encounter/actor request receipt before attempting another source mutation.
3. For a new update/discontinue action, lock and verify the owned MedicationUid, **Active** state and reviewed medication RowVersion. A foreign/missing resource returns no record; stale or noneditable state conflicts. Signed/reloaded contexts cannot bypass this.
4. Build the existing domain command using the extracted current builders, assign the **same connection and transaction**, and call **PatientMedication_Create / Update / Discontinue**. Consume all result sets/errors before treating the result as successful; no service call opens an independent write connection.
5. Call existing **PatientEncounterHistory_Create** in the same transaction, then commit before returning success. Any domain audit, history or transaction failure rolls back the medication, version, compliance revisions, audit and provenance. A nested procedure may already have rolled back the transaction; cleanup preserves the original error.

**All data modifications are stored-procedure calls.** Inline SQL in the new repository is SELECT-only context/resource/receipt validation. It neither updates a clinical row directly nor changes stored procedure definitions. No new wrapper procedure, table, column or migration is needed.

Source audit remains the existing **Create / Update / Discontinue — PatientMedication** with actual before/after values and trusted actor. New encounter history action values are **CppMedicationCreate / CppMedicationUpdate / CppMedicationDiscontinue**. Its ActionDescription contains the stable request UID, canonical typed-payload SHA-256 and resulting medication UID as a transactionally committed receipt. Clinical display uses the separate readable description. The existing source remains patient-owned; provenance does not duplicate it or reverse it after note signing/amendment.

Replays are scoped to the same patient, encounter and actor. The encounter lock serializes attempts. Matching action/payload returns the committed source identity without another source/audit/history write; changed payload/action with the same request ID conflicts. Receipt lookup precedes the source-version check so an already committed update/discontinue can be retried without reapplying it. Current authorization, Open encounter and encounter version remain required even for replay. Independent new request IDs can still record clinically legitimate separate medications; this is not name-based global deduplication.

Two SQL signing-order tests confirm that a Signed transition first prevents the medication write, while a medication transaction first holds the transition until source audit/provenance commit. These verify the shared row-lock protocol in isolated SQL; the deployed full signing/OIDC chain remains pending. No note text/status update or artificial encounter-version touch is introduced by medication management.

## 5. UI behavior and compatibility

The Bootstrap 5 inline panel sits beside the existing diagnosis/procedure and SOAP/structured Progress content. It exposes current medication fields and classifications, validation/length/date feedback and optional discontinuation reason. Unknown classification remains unknown. Editing preserves the selected UID and current token; discontinuation is separate and confirmed. Inactive/Discontinued and Signed contexts remain read-only. Reopening the display never changes Signed to Open; no addendum/reopen policy was added.

Procedure/medication/note/diagnosis/contribution saves coordinate their busy state; signing is blocked while medication edits are pending. Changing source context invalidates late responses. Errors preserve form/narrative input, require explicit reload and never automatically retry clinical mutations. The module never reads, copies or writes SOAP text to obtain a medication entry.

Successful saves perform a fresh source GET and refresh only medication/CPP content, preserving unsaved narrative. Ongoing CPP filtering and date order match the authoritative projection; unknown/Acute records are not mislabelled as missing globally. Existing **data-cpp-field** keys are retained so saved visibility preferences apply to new DOM through the existing observer. If persistence succeeds but refresh fails, the panel reports reload-required rather than claiming refreshed acceptance.

The UI uses labelled fields, keyboard controls, an accessible live status message and stacked narrow-screen fields. These are implementation/compiled-module observations; no real Chromium/mobile screenshot or comprehensive accessibility PASS is claimed here.

## 6. Automated results and evidence boundaries

| Verification | Final outcome |
|---|---|
| New Application/contract tests | **18 PASS**: read-only selection, four permission gates, actor spoof resistance, ownership/state/read-audit denial, validation, source/context versions, Web antiforgery and readable history fallback |
| New two-store SQL tests | **10 PASS**: create/update/discontinue and each replay, no duplicate rows/audits, actual CPP projection, retained plan/compliance/legacy state, both tenant directions, stale/Signed/actor rejection, source/late provenance rollback and both signing orders |
| New real prescription/artifact separation case | **1 PASS**: all new medication actions leave actual finalized prescription data and signed artifact unchanged |
| **New focused .NET total** | **29 distinct PASS / 0 FAIL / 0 skipped** in final outcomes |
| New compiled medication frontend | **5 behavior groups PASS**: existing selection/update/identity/tokens/double submission/SOAP; record/classify/discontinue/CPP; conflict/no blind retry; signed/restricted/reset; late-context isolation |
| Affected existing frontend | **Procedure module 4 behavior groups PASS** after its narrow reciprocal busy guard; **medication-classification.test.cjs 8 tests PASS** |
| Single final affected .NET/Release gate | **27 PASS / 0 FAIL / 0 skipped**: MedicationClassificationTests, MedicationClassificationCppTests, MedicationClassificationWebTests, EncounterDraftSaveTests and EncounterHistoryPrintTests |
| Build/type checks | Strict targeted TypeScript emit succeeded. Core/Application/Infrastructure/DatabaseTool/API/Web/tests built successfully in isolated Debug/Release output |

**56 distinct .NET cases have final PASS outcomes: 29 new + 27 affected.** The initial 17 contract cases overlap the final 18 and are not added. No Step 176 142-case rerun. Its unchanged SQL/diagnosis/security evidence is reused, not counted as new work. The affected Procedure frontend check was necessary for its changed busy guard and ran in the final frontend gate.

The first prescription-separation run failed in **test setup**, because the reused prescription fixture already supplied DisplayName and the new setup tried to add it again. Removed that duplicate setup line and reran only the affected new contract/prescription scope: **19/19 PASS**. This was not an application/schema defect or a reason to change production SQL. No failed final assertion remains.

Evidence under ignored `.tmp/step177/results/`:

- `step177-unit.trx`: initial 17 contract cases, retained historical successful run.
- `step177-sql.trx`: 10 SQL cases, PASS.
- `step177-prescription-separation.trx`: initial setup failure retained, not final acceptance.
- `step177-final-contract-and-prescription.trx`: final 18 contract + 1 prescription case, PASS.
- `step177-affected-regression.trx`: final affected gate 27/27, PASS.

Used the established bundled Node/TypeScript compiler and isolated `--artifacts-path .tmp/step177/build`. Focused filters named only the new test classes. Final gate used **Release**, `--no-restore`, the five affected classes above, and `-p:NuGetAudit=false`. Only one broader gate ran; no solution-wide suite, rebuild of running outputs or browser execution.

SQL fixtures explicitly used **(localdb)\MSSQLLocalDB / master / Windows integrated authentication** and validated generated disposable names, including the reused Step 69/87 fixture conventions. The family/classification fixture connection setting was unset and therefore used its established default LocalDB target. No shared database endpoint or account was used. All fixture schema/record setup and cleanup occurred only within those disposable tests.

The tests distinguish executed isolated Application/SQL/DOM behavior from authenticated deployment verification. Forged client actor values are ignored in favor of the actual accessor; no statement that all unknown JSON properties are rejected. No claimed real browser, live audit observation, medical-staff acceptance or external certification decision.

## 7. Migration status and later combined deployment acceptance

**New migration required: NO.** No `db/` file or manifest entry changed. The existing manifest remains **93 entries**, including Step 176's **0092-encounter-procedures** exactly once. No 0093 reserved/created. Neither 0092 nor any other migration was applied to a shared/production database in this step. Actual shared-tenant ledger/application state was deliberately not queried and is not newly certified.

Later combined Procedure/Medication work, under separate explicit scope:

1. **SELECT-only readiness first, no login.** Verify the exact approved development tenant/database, matching services/configuration and migration status, existing synthetic Open SOAP/Progress context, source procedure/medication IDs, versions, mapped actor/effective permissions and audit boundaries. Reuse Step 175's actual-schema fixture queries; do not assume a Family patient supplies a suitable Open note or medication fixture.
2. **Runtime SQL capability check.** This no-migration approach needs existing runtime permission to execute the medication and encounter-history procedures and to SELECT/lock the relevant patient, encounter, medication and receipt fields on the same connection. Isolated fixtures establish the algorithm, not the deployed principal's exact privileges. Verify using existing read-only metadata/approved readiness evidence; do not grant access or weaken tenant controls automatically. If that principal cannot support the approach without a new SQL deployment, stop for a separately authorized solution.
3. **Matching deployment authorization.** Use the existing controlled development workflow for pending 0092, only after confirmed identity/pending set and explicit approval; deploy matching API/Web/generated assets together. No permission/membership/fixture repair is implied. Step 176 records the actual DatabaseTool commands; none executed here.
4. **Bounded authenticated acceptance authorization.** Only after fixture readiness, authorize named normal sessions and exact clinical actions/counts. Automate Procedure record/update and medication existing-selection/record/update/discontinue, SQL-to-rendered CPP correlation, source row counts/versions/audits/provenance, private actor binding and no prescription/artifact changes. Include only missing desktop/mobile/label/focus assertions. Successful clinical mutations are intended writes and need explicit authorization; previous denied Family POST authorization cannot be reused.
5. **Fixture handling.** Prefer existing synthetic patients/Open notes/Surgical and medication records. If absent, propose minimal exact normal-workflow setup separately before login. Record baseline values/tokens and authorized changes. Retain audited test data unless restoration/archive/discontinue is separately authorized; never physically delete clinical rows or use SQL cleanup.
6. **Evidence closure.** Reconcile both missing encounter paths against the exact PC07.10 requirement and retained all-category/diagnosis evidence after real outcomes. Do not rerun completed isolated suites or reduce the inventory from code presence alone.

No new medication schema makes ordinary source-data compatibility straightforward, but deployment rollback must preserve committed medication changes and encounter-history receipts. Rolling back UI/API does not undo clinical data; do not compensate automatically. Procedure-kind/0092 forward-recovery limitations from Step 176 still apply to the combined release. No down migration or rollback execution is supplied.

## 8. Remaining risks, estimate and Step 178

Remaining qualifications: actual runtime SQL privileges; matching development deployment/migration; suitable Open-note fixtures and exact permitted mutation scope; normal-session tenant/actor routing; real browser/SQL/audit correlation and representative responsive/accessibility evidence. Clinician review and accepted release/source applicability remain separate. Isolated locking/security tests do not complete every previously deferred deployed adversarial scenario or any unrelated prescribing requirement.

**PC07.10 remains PARTIAL — IMPLEMENTED, with the missing procedure/medication encounter paths implemented and isolated verification complete, deployment acceptance pending.** PC07.01 remains PARTIAL. Inventory remains **8 IDs / three packages**: prescribing PC04.01/.06/.07/.09/.14; CPP PC07.01/.10; scheduling PC09.03. No unrelated status changes or reduction.

Estimated remaining active effort: **4–8 engineering hours** — readiness/matching deployment/explicitly authorized bounded acceptance **3–6 h**, final evidence reconciliation **1–2 h**. Assumes existing fixtures/accounts/SQL privileges and no new defect; any fixture creation, permission/deployment change, environment waiting, clinical-policy decision or external acceptance extends that estimate and needs its own scope. No overall certification completion date.

**Proposed Step 178: combined PC07.10 Procedure/Medication development deployment readiness and exact acceptance plan.** Default to targeted non-authenticated service checks, SELECT-only identity/fixture/permission/audit metadata and controlled pending-migration review. Report READY/PARTIAL/BLOCKED with exact missing prerequisites and proposed login/write counts; do not authenticate, deploy, apply 0092 or create fixtures until those actions receive explicit separate authorization. Reuse this step's and Step 176's successful tests without replay.

## 9. Final checks and stop

Only the bounded medication feature, necessary shared command/history/panel coordination, generated counterparts, new tests and this report changed. Previous Step 176 implementation/reports and all owner work preserved. Reviewed source parameter extraction, transaction/error handling, exact table/column/procedure names, current row/CPP lifecycle, non-prescription path, report links, manifest unchanged count and whitespace/final status. Compiler-only line-ending changes to an unchanged History helper were restored to its original bytes.

Current branch **feature/step-176-pc07-10-encounter-procedures**, based on the owner's current main commit, remains local and uncommitted for this step. No shared/production SQL access, new migration/table, deployment, service restart, clinical authentication, deployed fixture/write, commit, merge, push, reset, clean, stash or GitHub/remote operation. **Stop after implementation, verification and documentation.**
